Winton Group LTD Eli Lilly & CO Transaction History

Winton Group LTD

$1.31 Billion
Q3 2024

A detailed history of Winton Group LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Winton Group LTD holds 356 shares of LLY stock, worth $288,744. This represents 0.02% of its overall portfolio holdings.

Number of Shares

356

Previous 3,401 89.53%

Holding current value

$288,744

Previous $3.08 Million 89.77%

% of portfolio

0.02%

Previous 0.22%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $2.35 Million - $2.92 Million	-3,045 Reduced 89.53%	356 $315,000
Q2 2024 Aug 09, 2024	BUY	$724.87 - $909.04 $2.47 Million - $3.09 Million	3,401 New	3,401 $3.08 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $1.54 Million - $2.12 Million	-3,545 Reduced 38.75%	5,604 $3.01 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $1.54 Million - $2.06 Million	-4,384 Reduced 32.39%	9,149 $4.29 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $1.58 Million - $1.86 Million	5,094 Added 60.36%	13,533 $4.65 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $2.71 Million - $3.16 Million	8,439 New	8,439 $3.09 Million
Q2 2022 Aug 10, 2022	SELL	$278.73 - $327.27 $1.1 Million - $1.29 Million	-3,936 Reduced 39.96%	5,913 $1.92 Million
Q1 2022 May 11, 2022	BUY	$234.69 - $291.66 $629,438 - $782,232	2,682 Added 37.42%	9,849 $2.82 Million
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $546,160 - $677,788	2,429 Added 51.27%	7,167 $1.98 Million
Q3 2021 Oct 28, 2021	BUY	$221.6 - $272.71 $1.05 Million - $1.29 Million	4,738 New	4,738 $1.1 Million
Q2 2021 Aug 10, 2021	SELL	$180.55 - $233.54 $672,187 - $869,469	-3,723 Closed	0 $0
Q1 2021 Jul 21, 2021	BUY	$164.32 - $212.72 $611,763 - $791,956	3,723 New	3,723 $696,000
Q3 2020 Oct 30, 2020	SELL	$146.22 - $169.13 $187,161 - $216,486	-1,280 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$136.42 - $164.18 $174,617 - $210,150	1,280 New	1,280 $210,000
Q3 2019 Nov 08, 2019	SELL	$106.79 - $116.16 $554,346 - $602,986	-5,191 Closed	0 $0
Q2 2019 Jul 08, 2019	SELL	$110.79 - $129.32 $48,415 - $56,512	-437 Reduced 7.76%	5,191 $575,000
Q1 2019 May 13, 2019	SELL	$111.31 - $131.02 $5.15 Million - $6.06 Million	-46,247 Reduced 89.15%	5,628 $730,000
Q4 2018 Feb 05, 2019	BUY	$105.9 - $118.64 $5.49 Million - $6.15 Million	51,875 New	51,875 $6 Million
Q3 2018 Nov 02, 2018	SELL	$85.86 - $107.31 $281,277 - $351,547	-3,276 Closed	0 $0
Q2 2018 Aug 20, 2018	SELL	$75.7 - $86.88 $341,028 - $391,394	-4,505 Reduced 57.9%	3,276 $0
Q1 2018 May 21, 2018	BUY	$74.21 - $87.6 $72,577 - $85,672	978 Added 14.38%	7,781 $0
Q4 2017 Feb 13, 2018	SELL	$81.94 - $87.89 $477,874 - $512,574	-5,832 Reduced 46.16%	6,803 $575,000
Q3 2017 Nov 13, 2017	SELL	$77.07 - $85.54 $9,402 - $10,435	-122 Reduced 0.96%	12,635 $1.08 Million
Q2 2017 Aug 17, 2017	BUY	N/A	12,757	12,757 $1.05 Million

Others Institutions Holding LLY

# of Institutions

4,073

Shares Held

737M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $771B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Account